Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,401,476
+$22,360,689 QoQ
Shares Held
329,087
+62.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#151
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Derivatives in AZN
reported options exposure · as of Jun 30, 2026CallValue
$853,290
CallShares
4,500
PutValue
$663,670
PutShares
3,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. AZN ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,085,383 | $581,119,768 | |
| 2 | AMGN |
Amgen Inc
|
1,128,681 | $408,717,963 | |
| 3 | LLY |
ELI LILLY & Co
|
81,240 | $97,441,701 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
329,087 | $62,401,476 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
409,174 | $51,695,043 | |
| 6 | ABBV |
AbbVie Inc.
|
198,249 | $49,887,378 | |
| 7 | JNJ |
Johnson & Johnson
|
34,909 | $8,865,838 | |
| 8 | PFE |
Pfizer Inc
|
330,300 | $7,953,624 |
All Filings in AZN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $663,670 | 3,500 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $62,401,476 | 329,087 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $853,290 | 4,500 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $40,040,787 | 203,026 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,183,320 | 6,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $788,880 | 4,000 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||